These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10855949

  • 1. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
    Liu XX, Wilson K, Charlton CG.
    Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain.
    Waldmeier PC, Feldtrauer JJ.
    Biochem Pharmacol; 1987 Sep 01; 36(17):2855-61. PubMed ID: 3632711
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Brain ATP:L-methionine S-adenosyltransferase (MAT), S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH): regional distribution and age-related changes.
    Trolin CG, Löfberg C, Trolin G, Oreland L.
    Eur Neuropsychopharmacol; 1994 Dec 01; 4(4):469-77. PubMed ID: 7894257
    [Abstract] [Full Text] [Related]

  • 11. Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease.
    Cheng H, Gomes-Trolin C, Aquilonius SM, Steinberg A, Löfberg C, Ekblom J, Oreland L.
    Exp Neurol; 1997 Jun 01; 145(2 Pt 1):580-5. PubMed ID: 9217094
    [Abstract] [Full Text] [Related]

  • 12. Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa.
    Charlton CG, Crowell B.
    Life Sci; 2000 Apr 21; 66(22):2159-71. PubMed ID: 10834300
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L, Deng M, Zhang S, Lu S, Gui X, Fang Y.
    Biomed Pharmacother; 2017 Oct 21; 94():666-678. PubMed ID: 28787702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.
    Charlton CG, Mack J.
    Mol Neurobiol; 1994 Oct 21; 9(1-3):149-61. PubMed ID: 7888091
    [Abstract] [Full Text] [Related]

  • 18. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, reduces the peripheral O-methylation of L-DOPA and enhances its availability to the brain.
    Parada A, Soares-da-Silva P.
    Pharmacology; 2003 May 21; 68(1):29-37. PubMed ID: 12660477
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P, Di Rocco A, Prikhojan A, Rempel N, Bottiglieri T, Bressman S, Yahr MD.
    Brain Res; 2001 Mar 02; 893(1-2):278-81. PubMed ID: 11223018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.